A20 mRNA therapeutics ameliorate systemic sclerosis by suppressing TRAF-6/NF-KB signaling and DREAM expression and exerting antifibrotic effects
- A. Ram Lee
- , Su Been Jeon
- , Hye Won Kwak
- , Suh Won Yang
- , Yoo Jin Bang
- , Seon Yeong Lee
- , So Won Lee
- , Jin Hyung Park
- , Se Gyeong Han
- , Jeong Won Choi
- , Hyo Jung Park
- , Mi La Cho
- , Jae Hwan Nam
- Catholic University of Korea
- The Catholic University of Korea, College of Medicine
- The Catholic University of Korea
- SML Biopharm
Research output: Contribution to journal › Article › peer-review
3
Scopus
citations